These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 26001793)

  • 1. The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
    Di Minno G; Zotz RB; d'Oiron R; Bindslev N; Di Minno MN; Poon MC;
    Haematologica; 2015 Aug; 100(8):1031-7. PubMed ID: 26001793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
    Poon MC; d'Oiron R; Zotz RB; Bindslev N; Di Minno MN; Di Minno G;
    Haematologica; 2015 Aug; 100(8):1038-44. PubMed ID: 26001792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U; Laws HJ; Eisert S; Göbel U
    Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC; Di Minno G; d'Oiron R; Zotz R
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes.
    Zotz RB; Poon MC; Di Minno G; D'Oiron R;
    TH Open; 2019 Jul; 3(3):e286-e294. PubMed ID: 31523745
    [No Abstract]   [Full Text] [Related]  

  • 6. Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.
    Andiç N; Oğuz N; Gündüz E; Kiraz Bulduk T; Üsküdar Teke H
    Blood Coagul Fibrinolysis; 2021 Jul; 32(5):349-351. PubMed ID: 33878047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative haemostatic management of Glanzmann thrombasthenia for abdominal surgery.
    Lison S; Spannagl M; Heindl B
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):371-3. PubMed ID: 19367156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
    Poon MC; Zotz R; Di Minno G; Abrams ZS; Knudsen JB; Laurian Y
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S33-6. PubMed ID: 16427383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
    Javed A; Ayyub M; Abrar S; Mansoor M; Khan B; Hussain T
    J Ayub Med Coll Abbottabad; 2009; 21(2):171-3. PubMed ID: 20524499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions.
    Devecioğlu O; Unüvar A; Anak S; Bilge I; Ander H; Ziylan O
    Turk J Pediatr; 2003; 45(1):64-6. PubMed ID: 12718376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
    Poon MC
    Thromb Haemost; 2021 Mar; 121(3):332-340. PubMed ID: 33124022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of recombinant factor VII in Glanzmann thrombasthenia: a case report].
    Chabchoub Ben Abdallah R; Trabelsi L; Ben Ameur S; Kammoun F; Boukédi A; Ben Salah M; Ben Hlima N; Mahfoudh A
    Arch Pediatr; 2010 Jul; 17(7):1062-4. PubMed ID: 20570498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of bleeding and response to therapy in Glanzmann thrombasthenia.
    Borhany M; Fatima H; Naz A; Patel H; Shamsi T
    Haemophilia; 2012 Nov; 18(6):e423-5. PubMed ID: 22970800
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature.
    Rajpurkar M; Chitlur M; Recht M; Cooper DL
    Haemophilia; 2014 Jul; 20(4):464-71. PubMed ID: 24948404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of rFVIIa in 4 children with Glanzmann thrombasthenia.
    Valentino LA
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):653-8. PubMed ID: 17023825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia.
    Poon MC; Demers C; Jobin F; Wu JW
    Blood; 1999 Dec; 94(11):3951-3. PubMed ID: 10572113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia].
    Sugihara S; Katsutani S; Hyodo H; Hyodo M; Kudo Y; Fujii T; Kimura A
    Rinsho Ketsueki; 2008 Jan; 49(1):46-50. PubMed ID: 18277596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.
    Poon MC; d'Oiron R; Hann I; Négrier C; de Lumley L; Thomas A; Karafoulidou A; Demers C; Street A; Huth-Kühne A; Petrini P; Fressinaud E; Morfini M; Tengborn L; Marquès-Verdier A; Musso R; Devecioglu O; Houston DS; Lethagen S; Van Geet C; von Depka M; Berger C; Beurrier P; Britton HA; Gerrits W; Guthner C; Kuhle S; Lorenzo JJ; Makris PE; Nohe N; Paugy P; Pautard B; Torchet MF; Trillot N; Vicariot M; Wilde J; Winter M; Chambost H; Ingerslev J; Peters M; Strauss G
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):21-5. PubMed ID: 11735106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders.
    Croom KF; McCormack PL
    BioDrugs; 2008; 22(2):121-36. PubMed ID: 18345709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.